SBN 0.00% 0.0¢ sun biomedical limited

the oraline advantage

  1. 10,968 Posts.
    lightbulb Created with Sketch. 1206
    Now with only 3 weeks to go till the launch of Oraline 8, it is instructive to re-post this brief write-up (from 10 months ago) of Oraline iv's advantages over the other main POC saliva-based testing devices.

    Oraline iv was regarded as ahead of the pack then. How much more will this be so for Oraline 8?

    Oraline 8 has addressed the key 'challenge' posed in the article. That is, the need to test for multiple drugs. O8 will 'kill' the competition on that criteria.

    Great that there have been no new significant saliva-device releases from competitors this year.



    Friday, December 28, 2007
    Oral Screening Products

    The Oraline IV drug test is a new product for O.D.T. Recently, some questions about this oral fluid screen were asked. Here are the results:

    Oraline IV's nearest competitors in the market is the iScreen 4 and Oralscreen 4. The iScreen 4 is pretty popular by brand name, but no longer sold by O.D.T. As for the Oralscreen 4, one client was not pleased with the quality and workmanship nor the cut-off levels on the THC metabolite. This client converted its 1100 employees to using the Oraline IV.

    Oraline IV has the potential to be a market leader for several reasons. Its Samhsa approval has been granted meaning people in the states will begin looking for the Oraline IV product. Medical recognition is always a BIG thing, and that should help this product. Oraline IV is the first saliva drug testing kit to test for the parent drug THC (marijuana) at the SAMHSA recommmended cut-off level of 4ng/mL, rather than the metabolite.

    One of the challenges this product will face is expanding its product line to test more drugs in order to meet furthur demands.

    Posted by rpdxms at 9:07 AM 3 comments
    Labels: iscreen oral fluid, oraline, oraline iv, oralscreen 4

    http://rapidexams.blogspot.com/
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.